Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.
Debrix I, Tilleul P, Milleron B, Grené N, Bouleuc C, Roux D, Lioté H, Madelaine I, Bellanger A, Conort O, Fontan JE, Le Mercier F, Bardin C, Becker A. Debrix I, et al. Among authors: madelaine i. Clin Ther. 2001 Jul;23(7):1116-27. doi: 10.1016/s0149-2918(01)80095-3. Clin Ther. 2001. PMID: 11519774
Residual chemotherapy drugs after flushing infusion lines.
Marchal MA, Robert M, Pesqué R, Jourdan N, Sessink P, Madelaine I, Levert H. Marchal MA, et al. Among authors: madelaine i. J Oncol Pharm Pract. 2024 Mar;30(2):278-285. doi: 10.1177/10781552231175820. Epub 2023 May 30. J Oncol Pharm Pract. 2024. PMID: 37254519
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Lancet Oncol. 2019. PMID: 31492632
CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas.
Ta VA, Battistella M, Zhao LP, Dobos G, Ram-Wolff C, Madelaine I, Bories JC, Tournilhac O, Rouanet J, Veyrat-Masson R, Bouaziz JD, Marie-Cardine A, Bagot M, Bensussan A, Moins-Teisserenc H, De Masson A. Ta VA, et al. Among authors: madelaine i. J Invest Dermatol. 2023 Jul;143(7):1329-1332.e3. doi: 10.1016/j.jid.2023.01.009. Epub 2023 Jan 28. J Invest Dermatol. 2023. PMID: 36716922 Free article. No abstract available.
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).
Gallien S, Journot V, Rozenbaum W, Yéni P, Morlat P, Poizot-Martin I, Reynes J, Reliquet V, Leclercq P, Simon F, Chêne G, Molina JM; ALIZE (ANRS 099) Study Group. Gallien S, et al. J Antimicrob Chemother. 2011 Jan;66(1):184-91. doi: 10.1093/jac/dkq395. Epub 2010 Oct 28. J Antimicrob Chemother. 2011. PMID: 21036772 Clinical Trial.
A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.
Tilleul P, Brignone M, Hassani Y, Labrande C, Pedeboscq S, Gensollen S, Lahille B, Exinger D, Bertholle V, Billard M, Charlety D, Prebay D, Pinguet F, Taillibert S, Cartalat S, Chinot O, Borget I; Temozolomide Study Group of Société Française de Pharmacie Oncologique. Tilleul P, et al. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):828-34. doi: 10.1002/pds.3233. Epub 2012 Mar 15. Pharmacoepidemiol Drug Saf. 2012. PMID: 22419509
90 results